SH2 domain protein interaction and possibilities for pharmacological intervention
- 29 February 1996
- journal article
- review article
- Published by Elsevier in Cellular Signalling
- Vol. 8 (2) , 75-86
- https://doi.org/10.1016/0898-6568(95)02033-0
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Solid phase synthesis of peptides containing the non-hydrolysable analog of (O)phosphotyrosine, P(CH2PO3H2)PheInternational Journal of Peptide and Protein Research, 2009
- Direct demonstration of an intramolecular SH2—phosphotyrosine interaction in the Crk proteinNature, 1995
- Catalytic specificity of protein-tyrosine kinases is critical for selective signallingNature, 1995
- An Alternative to SH2 Domains for Binding Tyrosine-Phosphorylated ProteinsScience, 1994
- Cyclic Peptide Inhibitors of Phosphatidylinositol 3-Kinase p85 SH2 Domain BindingBiochemical and Biophysical Research Communications, 1994
- Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain bindingBiochemistry, 1993
- SH2 domains recognize specific phosphopeptide sequencesPublished by Elsevier ,1993
- cDNA cloning of a Novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF β-receptorCell, 1991
- Binding of SH2 Domains of Phospholipase Cγ1, GAP, and Src to Activated Growth Factor ReceptorsScience, 1990
- A PDGF receptor domain essential for mitogenesis but not for many other responses to PDGFNature, 1988